Latest filing published 08 Mar 2011 for KV PHARMACEUTICAL CO /DE/, €12k.
No signal scores available.
Arnold L. Hermelin appears in our data through filings on KV Pharmaceutical Co /DE/ shares, published by SEC (Form 4). We count 19 filings, every one of them for a trade on 4 March 2011.
On the market, this insider has only sold: 19 sales, €733k in total.
The record was last updated on 8 March 2011 with an open-market sale (€12k) in KV Pharmaceutical Co /DE/. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations